Keywords: کارسینوم درجا; penile neoplasms; neoplasm recurrence; local; organ sparing treatments; carcinoma; squamous cell; mortality; CIS; carcinoma in situ; LRFS; local recurrence-free survival; PSS; penile sparing surgery;
مقالات ISI کارسینوم درجا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کارسینوم درجا; Penile cancer; Recurrence; Model; Carcinoma in situ; High grade; Margins; Perineural invasion; Risk factors; Organ-sparing surgery;
Keywords: کارسینوم درجا; Bladder carcinoma; Cystectomy; Sexual function preserving; Prostate sparing; Neobladder; BC; bladder cancer; BCG; bacillus Calmette-Guérin; CSM; Cancer specific mortality; CSS; Cancer specific survival; CIS; carcinoma in situ; CIC; clean intermittent cat
Keywords: کارسینوم درجا; ureter; kidney; carcinoma in situ; urothelium; prognosis; BCG; bacillus Calmette-Guérin; B-CIS; bladder CIS; c-CIS; concomitant CIS; CIS; carcinoma in situ; CSS; cancer specific survival; p-CIS; pure/primary CIS; RNU; radical nephroureterectomy; UTUC; up
Keywords: کارسینوم درجا; urinary bladder neoplasms; hematuria; pathology; molecular; RNA; messenger; early detection of cancer; ABL1; ABL proto-oncogene 1; ANXA10; annexin 10; BCa; bladder cancer; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CRH; corticotropin releasin
Keywords: کارسینوم درجا; carcinoma in situ; early detection of cancer; Papanicolaou test; sensitivity and specificity; uterine cervical neoplasms;
Keywords: کارسینوم درجا; Biopsy; breast; breast neoplasms; carcinoma; carcinoma in situ; hyperplasia; intraductal; large-core needle; non-infiltrating;
Keywords: کارسینوم درجا; urinary bladder neoplasms; neoplasm invasiveness; neoplasm recurrence; local; BCG vaccine; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CR; complete response; DSS; disease specific survival; MIBC; muscle invasive bladder cancer; NMIB
Keywords: کارسینوم درجا; Lung cancer; Carcinoma in situ; Early detection; Sputum cytology; Autofluorescence bronchoscopy; Narrow band imaging; High magnification bronchovideoscope; Endocytoscopy;
Keywords: کارسینوم درجا; Esophageal Cancer; Genomics; Epigenomics; ADAR; adenosine deaminases acting on RNA; APOBEC; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like; BCH; basal cell hyperplasia; CIS; carcinoma in situ; CNA; copy number alteration; ESCC; esophagea
Keywords: کارسینوم درجا; Esophageal Cancer; Imaging; Early Detection; Accuracy; CIS; carcinoma in situ; ESCC; esophageal squamous cell carcinoma; ESD; esophageal squamous dysplasia; ESECC; esophageal cancer screening in China; EVL; endoscopically visualized lesion; NEVL; not endo
Keywords: کارسینوم درجا; BSGI; breast-specific gamma imaging; ER; estrogen receptor; PR; progesterone receptor; HER2; human epidermal growth factor receptor 2; CIS; carcinoma in situ; EIC; extensive intraductal component; Breast; Neoplasms; Radionuclide imaging; Mammography; Path
Keywords: کارسینوم درجا; TGCTs; testicular germ cell tumors; GCNIS; germ cell neoplasia in situ; ESCs; embryonic stem cells; ECCs; embryonal carcinoma cells; PGCs; primordial germ cells; IGCNU; Intratubular germ cell neoplasia of the unclassified type; CIS; Carcinoma in Situ; hPG
Keywords: کارسینوم درجا; Argon plasma coagulation; Carboplatin; Carcinoma in situ; Etoposide; Small-cell lung cancer;
Keywords: کارسینوم درجا; CIS; carcinoma in situ; MIBC; muscle-invasive bladder cancer; NMIBC; non-muscle-invasive bladder cancer; RC; radical cystectomy; TURBT; transurethral resection of bladder tumour; Bladder cancer; TURBT; T1G3;
Keywords: کارسینوم درجا; Bladder cancer; Radical cystectomy; pTis; Carcinoma in situ; Cancer-specific survival; Recurrence;
Keywords: کارسینوم درجا; CIS; carcinoma in situ; RNU; radical nephroureterectomy; UTUC; upper tract urothelial carcinoma; Urological neoplasms; Transitional cell carcinoma; Ureteric neoplasms; Urinary bladder neoplasms; Intravesical recurrence;
Keywords: کارسینوم درجا; AO; aorta; ASA; American Society of Anesthesiologists; BMI; body mass index; CI; confidence interval; CIS; carcinoma in situ; CRTx; chemoradiotherapy; CT; computed tomography; CTx; chemotherapy; GEJ; gastroesophageal junction; GT; gastric tube; HH; hiatal
Keywords: کارسینوم درجا; BMI; body mass index; CIS; carcinoma in situ; CRP; C-reactive protein; CSS; cancer-specific survival; DSNB; dynamic sentinel node biopsy; EAU; European Association of Urology; HPV; human papillomavirus; ILND; inguinal lymph node dissection; IQR; interquar
Keywords: کارسینوم درجا; 5ALA; 5-aminolevulinic acid; CIS; carcinoma in situ; CTU; CT urogram; HAL; hexaminolaevulinate; HNPCC; non-polyposis colorectal carcinoma; NBI; narrow-band imaging; PDD; photodynamic diagnosis; PPIX; protoporphyrin IX; PRISMA; Preferred Reporting Items fo
Keywords: کارسینوم درجا; Preinvasive disease; Squamous cell carcinoma; Lung cancer; Carcinoma in situ; Autofluorescence bronchoscopy; Bronchoscopic treatment;
Keywords: کارسینوم درجا; urinary bladder neoplasms; cystoscopy; aminolevulinic acid; photochemotherapy; drug-related side effects and adverse reactions; AE; adverse event; BLC; blue light cystoscopy; CIS; carcinoma in situ; CTCAE; Common Terminology Criteria for Adverse Events; F
Keywords: کارسینوم درجا; urinary bladder neoplasms; cystectomy; stents; nephrostomy; percutaneous; neoplasm recurrence; local; BC; bladder cancer; CIS; carcinoma in situ; CSS; cancer specific survival; CT; computerized tomography; IVP; excretory urography; RC; radical cystectomy;
Keywords: کارسینوم درجا; BCG vaccine; cancer vaccines; cell cycle checkpoints; immunotherapy; urologic neoplasms; AE; adverse event; APC; antigen presenting cell; BCG; bacillus Calmette-Guérin; CAR; chimeric antigen receptor; CIS; carcinoma in situ; CTA; cancer testis antigen; C
Keywords: کارسینوم درجا; carcinoma; transitional cell; recurrence; prognosis; nomograms; CHAID; chi-square automatic interaction detection; CIS; carcinoma in situ; F1; F measure; LND; lymphadenectomy; LOOCV; leave-one-out cross-validation; LVI; lymphovascular invasion; RFS; relap
Keywords: کارسینوم درجا; Cornea; Conjunctiva; Lymphoma; Melanoma; Ocular surface squamous neoplasia (OSSN); Optical coherence tomography (OCT); Pterygium; Tumor; CIS; carcinoma in situ; HR-OCT; high resolution optical coherence tomography; LSCD; limbal stem cell deficiency; MMP;
Keywords: کارسینوم درجا; Cancer Screening; Risk Stratification; Cost Effectiveness; Individualized Assessment; AIC; Akaike information criterion; AUC; area under the curve; BMI; body mass index; CI; confidence interval; CIS; carcinoma in situ; ESCC; esophageal squamous cell carci
Keywords: کارسینوم درجا; organ sparing treatments; penile neoplasms; treatment outcome; quality of life; CIS; carcinoma in situ; FS; frozen section; GL; glansectomy; GR; glans resurfacing; IIEF-15; International Index of Erectile Function; MMS; Mohs micrographic surgery; Nd:YAG;
Keywords: کارسینوم درجا; Basaloid squamous cell carcinoma; Uvula; Carcinoma in situ; Sequential cancerization; Precancerous lesions
Keywords: کارسینوم درجا; Oral cancer; Oral premalignant lesions; Dysplasia; Treatment; Cancer progression; SCC; squamous cell carcinoma; CIS; carcinoma in situ; BC; British Columbia;
Keywords: کارسینوم درجا; Photodynamic therapy; Levulan; Head and neck cancer; Severe dysplasia; Carcinoma in situ; ALA; PDT; Aminolevulinic acid; Protoporphyrin IX
Keywords: کارسینوم درجا; urinary bladder neoplasms; cystectomy; neoplasm recurrence; local; patient selection; morbidity; BCa; bladder cancer; BCG; bacillus Calmette-Guérin; CG; Clavien grade; CIS; carcinoma in situ; DSS; disease specific survival; LVI; lymphovascular invasion;
Keywords: کارسینوم درجا; CIS, carcinoma in situ; NBI, Narrow Band Imaging Bronchoscopy; NPV, negative predictive value; PPV, positive predictive value; WLB, white light bronchoscopyNarrow band imaging (NBI); White light bronchoscopy (WLB); Premalignant lesions; Carcinoma in situ
Keywords: کارسینوم درجا; Bronche; Endoscopie bronchique; Traitement endoscopique; Carcinome in situ; Bronchus; Bronchoscopy; Endoscopic treatment; Carcinoma in situ;
Keywords: کارسینوم درجا; Breast cancer; Triple-negative tumors; Carcinoma in situ; Prognostic markers; Recurrence; Magnetic resonance imaging; Diffusion; Perfusion; Ki67; p53Cáncer de mama; Tumores triple negativo; Carcinoma in situ; Marcadores pronósticos; Recidiva; Resonancia m
Keywords: کارسینوم درجا; Perlecan; Perlecan-binding growth factors; Oral squamous cell carcinoma; Carcinoma in situ; Epithelial dysplasia; Cell proliferating zone;
Keywords: کارسینوم درجا; Cáncer de mama; Tumores triple negativo; Carcinoma in situ; Marcadores pronósticos; Recidiva; Resonancia magnética; Difusión; Perfusión; ki67; p53Breast cancer; Triple-negative tumors; Carcinoma in situ; Prognostic markers; Recurrence; Magnetic resonance
Keywords: کارسینوم درجا; 2D; two-dimensional; 3D; three-dimensional; APC; adenomatous polyposis coli; BCC; basal cell carcinoma; BM; basement membrane; CEA; carcinoembryonic antigen; CIS; carcinoma in situ; CNS; central nervous system; ECM; extracellular matrix; IHC; immunohistoc
Keywords: کارسینوم درجا; Adenocarcinoma in situ; Carcinoma in situ; Squamous cell lesions; Cervix; Conization; Recurrence;
Keywords: کارسینوم درجا; urinary bladder neoplasms; biopsy; neoplasm recurrence; local; cystoscopy; cytology; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CT; computerized tomography; PFS; progression-free survival; RFS; recurrence-free survival; TURBT; transurethral r
Keywords: کارسینوم درجا; urinary bladder neoplasms; ureteral neoplasms; cystectomy; frozen section; biopsy; CIS; carcinoma in situ; DSS; disease specific survival; IUFS; intraoperative ureteral frozen section; OS; overall survival; UTR; upper tract recurrence;
Keywords: کارسینوم درجا; AUC; area under the curve; CIS; carcinoma in situ; IQR; interquartile range; NBI; narrow band imaging; OB; optical biopsy; PD; photodynamic diagnostic; PDT; photodynamic therapy; PPIX; protoporphyrin IX; US; ultrasonography; Optical spectrometry; Optical
Keywords: کارسینوم درجا; PAR-2; Oral mucosa; Squamous cell carcinoma; Carcinoma in situ; Cell proliferation; Cell invasion
Keywords: کارسینوم درجا; Nonmuscle invasive bladder cancer; High-risk bladder cancer; High-grade T1; HGT1; Carcinoma in situ; CIS; TUR; reTUR;
Keywords: کارسینوم درجا; Adenocarcinoma; Renal pevis; Carcinoma in situ; Ureter
Keywords: کارسینوم درجا; Breast cancer; Re-resection; Invasive carcinoma; Carcinoma in situ; Palpability; Neoadjuvant chemotherapy
Keywords: کارسینوم درجا; incidence; urinary bladder neoplasms; neoplasm staging; Spain; BC; bladder cancer; BCG; bacillus Calmette-Guérin; BMI; body mass index; CIS; carcinoma in situ; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral bladder tumor
Keywords: کارسینوم درجا; Bowen's disease; bowenoid papulosis; carcinoma in situ; dyspareunia; erythroplasia; foreskin; Kaposi; lichen planus; lichen sclerosus; penis; psoriasis; pyoderma gangrenosum; Zoon's
Keywords: کارسینوم درجا; urinary bladder; carcinoma; papillary; evidence-based practice; practice guideline; risk; AUA; American Urological Association; CIS; carcinoma in situ; CTU; computerized tomography urogram; EAU; European Association of Urology; ICUD; International Consult
Keywords: کارسینوم درجا; urinary bladder; carcinoma; urothelium; gene expression; biological markers; CIS; carcinoma in situ; Cq; cycle quantification; HG; high grade; LG; low grade; LOOCV; leave-one-out cross validation; MIBC; muscle invasive bladder cancer; NMIBC; nonMIBC; PCR;